Back to Journals » Patient Related Outcome Measures » Volume 9

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date

Total article views   HTML views PDF downloads Totals
19,616 Dovepress* 12,093+ 1,841 13,934
PubMed Central* 7,523 1,298 8,821
Totals 19,616 3,139 22,755
*Since 2 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
3 0 0 0 1 2

View citations on PubMed Central and Google Scholar